X0306 4 2023-02-18 0001531048 Inari Medical, Inc. NARI 0001806431 Hykes Andrew C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 1 President and CEO Common Stock 2023-02-18 4 A 0 46549 0 A 139595 D Common Stock 2023-02-21 4 S 0 9000 55.19 D 130595 D Common Stock 1550 I By Child 1 Common Stock 1550 I By Child 2 Common Stock 1550 I By Child 3 Common Stock 1000 I By Spouse Stock Options (Right to Buy) 56.00 2023-02-18 4 A 0 36085 56.00 A 2030-02-17 Common Stock 36085 36085 D 2023 Annual Restricted Stock Units grant ("RSUs"). Vesting Commencement Date begins January 1, 2023, 1/16th of the RSUs shall vest on each quarterly anniversary of the vesting Commencement Date. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. This transaction was executed in multiple trades at prices ranging from $55.00 to $55.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023. /s/ Angela Ahmad, attorney-in-fact for Andrew Hykes 2023-02-22